Related Experiment Video

Updated: Jun 10, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Improving risk stratification for cardiovascular disease

Diederik F van Wijk1, S Matthijs Boekholdt

  • 1Academic Medical Center, Department of Vascular Medicine, B2-238, PO Box 22660, 1100 DD, Amsterdam, The Netherlands. d.f.vanwijk@amc.uva.nl

Expert Review of Cardiovascular Therapy
|July 31, 2010
PubMed

Insights

Identifying high-risk cardiovascular patients is crucial. New research suggests combining inflammatory and oxidative markers enhances cardiovascular mortality prediction in stable coronary artery disease, improving traditional risk models.

Area of Science:

  • Cardiology
  • Biomarkers
  • Preventive Medicine

Background:

  • Cardiovascular disease prevention relies on accurate risk identification.
  • Inflammatory and oxidative markers show promise in enhancing cardiovascular risk prediction.
  • Existing models need improvement for predicting cardiovascular events.

Discussion:

  • This study assesses a publication on inflammatory and oxidative markers for predicting cardiovascular mortality.
  • It examines how these markers contribute to risk stratification in patients with stable coronary artery disease.
  • The findings are contextualized within broader cardiovascular risk prediction strategies.

Key Insights:

  • Multiple inflammatory and oxidative markers can enhance the predictive accuracy of traditional cardiovascular risk models.
  • Combining various markers offers a more comprehensive approach to risk assessment.
  • This supports the integration of novel biomarkers into clinical practice for better patient outcomes.

Outlook:

  • Further research is needed to validate the clinical utility of combined markers.
  • Exploring optimal combinations and thresholds for different patient populations is essential.
  • These advancements could lead to more personalized and effective cardiovascular disease prevention strategies.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...